Hartline Investment Corp’s Colgate-Palmolive CL Stock Holding History

Hartline Investment Corp’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Hold	2,500	–	–	0.02%	109
2026 Q1	$213K	Buy	+2,500	New	+$223K	0.02%	104
2025 Q3	–	Sell	-2,500	Closed	-$227K	–	115
2025 Q2	$227K	Hold	2,500	–	–	0.03%	101
2025 Q1	$234K	Sell	2,500 -600	-19%	-$53.7K	0.03%	94
2024 Q4	$282K	Hold	3,100	–	–	0.03%	87
2024 Q3	$322K	Hold	3,100	–	–	0.04%	87
2024 Q2	$301K	Buy	+3,100	New	+$286K	0.04%	87
2024 Q1	–	Sell	-3,100	Closed	-$247K	–	418
2023 Q4	$247K	Hold	3,100	–	–	0.04%	97
2023 Q3	$220K	Hold	3,100	–	–	0.04%	100
2023 Q2	$239K	Hold	3,100	–	–	0.04%	99
2023 Q1	$233K	Hold	3,100	–	–	0.05%	97
2022 Q4	$244K	Buy	+3,100	New	+$232K	0.06%	96
2022 Q3	–	Sell	-4,034	Closed	-$345K	–	166
2022 Q2	$345K	Buy	4,034 +904	+29%	+$70.7K	0.05%	93
2022 Q1	$255K	Hold	3,130	–	–	0.03%	113
2021 Q4	$267K	Hold	3,130	–	–	0.04%	107
2021 Q3	$237K	Hold	3,130	–	–	0.03%	114
2021 Q2	$255K	Sell	3,130 -904	-22%	-$73.9K	0.03%	113
2021 Q1	$318K	Hold	4,034	–	–	0.05%	104
2020 Q4	$345K	Hold	4,034	–	–	0.05%	93
2020 Q3	$311K	Hold	4,034	–	–	0.05%	89
2020 Q2	$296K	Hold	4,034	–	–	0.06%	89
2020 Q1	$268K	Sell	4,034 -452	-10%	-$31.9K	0.07%	97
2019 Q4	$309K	Buy	4,486 +452	+11%	+$30.8K	0.07%	103
2019 Q3	$297K	Hold	4,034	–	–	0.07%	99
2019 Q2	$289K	Hold	4,034	–	–	0.07%	102
2019 Q1	$276K	Hold	4,034	–	–	0.07%	101
2018 Q4	$240K	Hold	4,034	–	–	0.07%	103
2018 Q3	$270K	Hold	4,034	–	–	0.06%	99
2018 Q2	$261K	Hold	4,034	–	–	0.07%	94
2018 Q1	$289K	Hold	4,034	–	–	0.08%	93
2017 Q4	$304K	Hold	4,034	–	–	0.08%	97
2017 Q3	$294K	Hold	4,034	–	–	0.09%	96
2017 Q2	$299K	Hold	4,034	–	–	0.1%	94
2017 Q1	$295K	Hold	4,034	–	–	0.09%	96
2016 Q4	$264K	Hold	4,034	–	–	0.09%	97
2016 Q3	$299K	Hold	4,034	–	–	0.11%	93
2016 Q2	$295K	Buy	4,034 +904	+29%	+$64.4K	0.11%	94
2016 Q1	$221K	Hold	3,130	–	–	0.08%	106
2015 Q4	$209K	Buy	+3,130	New	+$208K	0.08%	105
2015 Q3	–	Sell	-3,130	Closed	-$205K	–	105
2015 Q2	$205K	Hold	3,130	–	–	0.07%	106
2015 Q1	$217K	Hold	3,130	–	–	0.07%	103
2014 Q4	$217K	Hold	3,130	–	–	0.07%	105
2014 Q3	$204K	Hold	3,130	–	–	0.07%	110
2014 Q2	$213K	Hold	3,130	–	–	0.08%	106
2014 Q1	$203K	Hold	3,130	–	–	0.07%	106
2013 Q4	$204K	Buy	+3,130	New	+$200K	0.07%	104

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Hartline Investment Corp's CL Position: Q2 2026 in Review

Hartline Investment Corp held its Colgate-Palmolive (CL) position steady in Q2 2026 at 2,500 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #109.

Hartline Investment Corp first reported a position in CL in Q4 2013 and has held it in 46 quarters since. The position peaked at $345K in Q2 2022. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Hartline Investment Corp held 2,500 shares of Colgate-Palmolive worth $229K as of Q2 2026.
Hartline Investment Corp left its Colgate-Palmolive share count unchanged in Q2 2026.
Colgate-Palmolive made up 0.02% of Hartline Investment Corp's portfolio in Q2 2026, its #109 holding.
Hartline Investment Corp first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 46 quarters since.
Hartline Investment Corp's Colgate-Palmolive position peaked at $345K in Q2 2022.
2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Hartline Investment Corp's 13F filing for Q2 2026, filed 29 Jul 2026.